Synthesis, antimicrobial and antitubercular activities of some novel pyrazoline derivatives
In the present study, two new series of pyrazolines (3a–h &4a–h) were synthesized starting from p-acetamidophenol (paracetamol) and evaluated for their antibacterial, antifungal and antitubercular activities. Chalcones (2a–h) prepared by condensing 3-acetyl-4-hydroxyphenyl acetamide (1) with dif...
Saved in:
Published in: | Journal of Saudi Chemical Society Vol. 20; no. 5; pp. 577 - 584 |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Riyadh, Saudi Arabia
Elsevier B.V
01-09-2016
Saudi Chemical Society Elsevier |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | In the present study, two new series of pyrazolines (3a–h &4a–h) were synthesized starting from p-acetamidophenol (paracetamol) and evaluated for their antibacterial, antifungal and antitubercular activities. Chalcones (2a–h) prepared by condensing 3-acetyl-4-hydroxyphenyl acetamide (1) with different aromatic aldehydes were reacted with phenyl hydrazine and isonicotinic acid hydrazide to obtain phenyl-pyrazolines (3a–h) and isoniazid-pyrazolines (4a–h), respectively. The structures of the synthesized compounds were confirmed by spectral and microanalysis studies. Newly prepared pyrazoline compounds exhibited significant antibacterial activity against the organisms Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa when compared with the standard antibiotic Ciprofloxacin. Compound 4g showed potent antibacterial activity against P. aeruginosa and S. aureus (MIC-3.12μg/mL), however, against E. coli compound 3d, 4c, 4d, 4f &4g were found to have an MIC of 6.25μg/mL. Antifungal activity of compound 4d against Candida albicans and Aspergillus niger (MIC-3.12μg/mL) was found to be better than the standard drug Ketoconazole. The results of antitubercular activity of the synthesized compounds against Mycobacterium tuberculosis H37Rv by the agar microdilution method are quite promising. The antitubercular activity of compounds 4c, 4d &4g (MIC-3.12μg/mL) was found to be superior than that of the reference drug Streptomycin which showed MIC equal to 6.25μg/mL. It was observed that pyrazolines with chloro, nitro or methoxy substituent showed better activity. Also, the pyrazolines derived from isoniazid (4a–h) were found to be better in their antibacterial, antifungal and antitubercular action than those derived from phenyl-hydrazine (3a–h). |
---|---|
AbstractList | In the present study, two new series of pyrazolines (3a–h &4a–h) were synthesized starting from p-acetamidophenol (paracetamol) and evaluated for their antibacterial, antifungal and antitubercular activities. Chalcones (2a–h) prepared by condensing 3-acetyl-4-hydroxyphenyl acetamide (1) with different aromatic aldehydes were reacted with phenyl hydrazine and isonicotinic acid hydrazide to obtain phenyl-pyrazolines (3a–h) and isoniazid-pyrazolines (4a–h), respectively. The structures of the synthesized compounds were confirmed by spectral and microanalysis studies. Newly prepared pyrazoline compounds exhibited significant antibacterial activity against the organisms Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa when compared with the standard antibiotic Ciprofloxacin. Compound 4g showed potent antibacterial activity against P. aeruginosa and S. aureus (MIC-3.12μg/mL), however, against E. coli compound 3d, 4c, 4d, 4f &4g were found to have an MIC of 6.25μg/mL. Antifungal activity of compound 4d against Candida albicans and Aspergillus niger (MIC-3.12μg/mL) was found to be better than the standard drug Ketoconazole. The results of antitubercular activity of the synthesized compounds against Mycobacterium tuberculosis H37Rv by the agar microdilution method are quite promising. The antitubercular activity of compounds 4c, 4d &4g (MIC-3.12μg/mL) was found to be superior than that of the reference drug Streptomycin which showed MIC equal to 6.25μg/mL. It was observed that pyrazolines with chloro, nitro or methoxy substituent showed better activity. Also, the pyrazolines derived from isoniazid (4a–h) were found to be better in their antibacterial, antifungal and antitubercular action than those derived from phenyl-hydrazine (3a–h). In the present study, two new series of pyrazolines (3a–h & 4a–h) were synthesized starting from p-acetamidophenol (paracetamol) and evaluated for their antibacterial, antifungal and antitubercular activities. Chalcones (2a–h) prepared by condensing 3-acetyl-4-hydroxyphenyl acetamide (1) with different aromatic aldehydes were reacted with phenyl hydrazine and isonicotinic acid hydrazide to obtain phenyl-pyrazolines (3a–h) and isoniazid-pyrazolines (4a–h), respectively. The structures of the synthesized compounds were confirmed by spectral and microanalysis studies. Newly prepared pyrazoline compounds exhibited significant antibacterial activity against the organisms Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa when compared with the standard antibiotic Ciprofloxacin. Compound 4g showed potent antibacterial activity against P. aeruginosa and S. aureus (MIC-3.12 μg/mL), however, against E. coli compound 3d, 4c, 4d, 4f & 4g were found to have an MIC of 6.25 μg/mL. Antifungal activity of compound 4d against Candida albicans and Aspergillus niger (MIC-3.12 μg/mL) was found to be better than the standard drug Ketoconazole. The results of antitubercular activity of the synthesized compounds against Mycobacterium tuberculosis H37Rv by the agar microdilution method are quite promising. The antitubercular activity of compounds 4c, 4d & 4g (MIC-3.12 μg/mL) was found to be superior than that of the reference drug Streptomycin which showed MIC equal to 6.25 μg/mL. It was observed that pyrazolines with chloro, nitro or methoxy substituent showed better activity. Also, the pyrazolines derived from isoniazid (4a–h) were found to be better in their antibacterial, antifungal and antitubercular action than those derived from phenyl-hydrazine (3a–h). In the present study, two new series of pyrazolines (3a–h & 4a–h) were synthesized starting from p-acetamidophenol (paracetamol) and evaluated for their antibacterial, antifungal and antitubercular activities. Chalcones (2a–h) prepared by condensing 3-acetyl-4-hydroxyphenyl acetamide (1) with different aromatic aldehydes were reacted with phenyl hydrazine and isonicotinic acid hydrazide to obtain phenyl-pyrazolines (3a–h) and isoniazid-pyrazolines (4a–h), respectively. The structures of the synthesized compounds were confirmed by spectral and microanalysis studies. Newly prepared pyrazoline compounds exhibited significant antibacterial activity against the organisms Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa when compared with the standard antibiotic Ciprofloxacin. Compound 4g showed potent antibacterial activity against P. aeruginosa and S. aureus (MIC-3.12 lg/mL), however, against E. coli compound 3d, 4c, 4d, 4f & 4g were found to have an MIC of 6.25 lg/mL. Antifungal activity of compound 4d against Candida albicans and Aspergillus niger (MIC-3.12 lg/mL) was found to be better than the standard drug |
Author | Mujeeb, Mohd Husain, Asif Bhandari, Anil Ahmad, Aftab Khan, Shah Alam |
Author_xml | – sequence: 1 givenname: Aftab surname: Ahmad fullname: Ahmad, Aftab email: aftab786sa@hotmail.com, abdulsalam@kau.edu.sa organization: Health Information Technology Department, Jeddah Community College, King Abdulaziz University, Jeddah 21589, Saudi Arabia – sequence: 2 givenname: Asif surname: Husain fullname: Husain, Asif email: drasifhusain@yahoo.com organization: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hamdard University, New Delhi, India – sequence: 3 givenname: Shah Alam surname: Khan fullname: Khan, Shah Alam organization: Department of Pharmacy, Oman Medical College, Muscat, Oman – sequence: 4 givenname: Mohd surname: Mujeeb fullname: Mujeeb, Mohd organization: Department of Pharmacognosy & Phytochemistry, Faculty of Pharmacy, Hamdard University, New Delhi, India – sequence: 5 givenname: Anil surname: Bhandari fullname: Bhandari, Anil organization: Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Jodhpur National University, Jodhpur, Rajasthan, India |
BookMark | eNp9kMtKxDAUhrNQ8PoCgtAHcGqSaZMU3MjgDQQX6spFOE1ONKXTDEkdGJ_edEZmaTYh5_z_R_hOyMEQBiTkgtGSUSauu7JLJpWcsqpkvKS0OiDHbM6amWB0fkTOU-rodCTlVB2Tj9fNMH5h8umqgGH0S29iaD30-WW3k_G7xWi-e4gFmNGv_egxFcEVKSyxGMIa-2K1ifATej9gYTH6NeQcpjNy6KBPeP53n5L3-7u3xePs-eXhaXH7PDNzwcdZ21jrJKtkxQVVUljVKEOFc2CYkaxRdU6AhZpZyl2rWhBSqUpZxFpZYeen5GnHtQE6vYp-CXGjA3i9HYT4qSGO3vSoLYfaiJY1Rroqs4GZVla1dLIBats6s_iOlTWkFNHteYzqybDu9GRYT4Y14zobzqXLXQlzEh3sO5KKup72N3_7bGHtMepkPA4GrY9oxvxN_x_-F6zxlJE |
CitedBy_id | crossref_primary_10_1039_C8RA05702H crossref_primary_10_3390_molecules24030569 crossref_primary_10_1007_s00894_023_05688_0 crossref_primary_10_32895_UMP_MPR_6_1_6 crossref_primary_10_1002_slct_202304483 crossref_primary_10_1007_s11164_018_3305_4 crossref_primary_10_1080_15257770_2021_1985517 crossref_primary_10_1039_D4RA00365A crossref_primary_10_1021_acsomega_3c06936 crossref_primary_10_1016_j_saa_2023_123715 crossref_primary_10_1007_s42250_021_00311_2 crossref_primary_10_1002_ddr_21638 crossref_primary_10_1016_j_jphotochem_2017_10_010 crossref_primary_10_1016_j_molstruc_2021_131473 crossref_primary_10_1016_j_rechem_2023_101194 crossref_primary_10_2174_1389557520666200711173149 crossref_primary_10_2174_1570180819666220420092723 crossref_primary_10_37285_ijpsn_2023_16_1_5 crossref_primary_10_1080_15257770_2021_2011915 crossref_primary_10_1016_j_ejmech_2015_10_047 crossref_primary_10_17714_gumusfenbil_830149 crossref_primary_10_1080_10406638_2017_1363060 crossref_primary_10_2174_1570178618666210427103249 crossref_primary_10_2174_1385272827666230816105258 crossref_primary_10_1016_j_molstruc_2024_138045 crossref_primary_10_1080_10406638_2021_1885455 crossref_primary_10_1002_jhet_3631 crossref_primary_10_2174_2211352520666220307102523 crossref_primary_10_2174_1385272824999200922090524 crossref_primary_10_32948_ajpt_2022_12_30 crossref_primary_10_1080_10406638_2019_1614637 crossref_primary_10_2174_1568026620666200819151342 crossref_primary_10_1007_s11094_016_1438_6 crossref_primary_10_2174_1871526522666221004152324 crossref_primary_10_1002_ardp_201900351 crossref_primary_10_1016_j_rechem_2022_100606 crossref_primary_10_36106_ijsr_9527056 crossref_primary_10_1002_ajoc_202100699 crossref_primary_10_1039_D3OB01629C crossref_primary_10_2174_1386207323666200428091306 crossref_primary_10_2174_1573407214666180730104941 crossref_primary_10_1155_2016_7425913 crossref_primary_10_1016_j_bmc_2017_02_025 crossref_primary_10_1111_cbdd_13386 crossref_primary_10_1002_slct_202103984 crossref_primary_10_1016_j_tetlet_2019_151416 crossref_primary_10_2174_1389557519666181210162003 crossref_primary_10_53879_id_54_04_10781 crossref_primary_10_1134_S1068162020030152 crossref_primary_10_1007_s00044_020_02602_8 crossref_primary_10_1021_acsomega_3c00529 crossref_primary_10_1016_j_bioorg_2020_104063 crossref_primary_10_1039_D3RA04309F crossref_primary_10_1039_C6RA09703K crossref_primary_10_1080_00397911_2019_1627457 crossref_primary_10_1155_2017_6873924 crossref_primary_10_1515_ncrs_2021_0127 crossref_primary_10_55938_ijgasr_v3i1_70 crossref_primary_10_1016_j_molstruc_2021_132063 |
Cites_doi | 10.3390/molecules13041011 10.1016/j.biopha.2011.04.005 10.4103/0250-474X.40344 10.1007/s12223-008-0003-4 10.1007/s00044-012-0137-4 10.3390/molecules17054962 10.1007/s00044-012-0045-7 10.1007/s00044-011-9912-x 10.1016/j.ejmech.2006.09.006 10.1016/j.gpb.2012.04.002 10.1016/j.bmcl.2011.05.061 10.1517/13543776.2012.667403 10.1016/j.ejmech.2007.10.032 |
ContentType | Journal Article |
Copyright | 2014 The Authors |
Copyright_xml | – notice: 2014 The Authors |
DBID | 6I. AAFTH ADJCN AHFXO AAYXX CITATION DOA |
DOI | 10.1016/j.jscs.2014.12.004 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete CrossRef DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry |
EndPage | 584 |
ExternalDocumentID | oai_doaj_org_article_d2a5c6b19c7f4719a1cb7457f79a0db5 10_1016_j_jscs_2014_12_004 706554 S1319610314001835 |
GroupedDBID | --K 0R~ 0SF 1B1 4.4 457 5VS 6I. 71M AACTN AAEDT AAEDW AAFTH AAFWJ AAIKJ AALRI AAQFI AAXUO ABMAC ACGFS ADBBV ADEZE ADMUD AENEX AEXQZ AFPKN AFTJW AGHFR AITUG ALMA_UNASSIGNED_HOLDINGS AMRAJ BCNDV DU5 E3Z EBS EJD EP3 FDB FNPLU GROUPED_DOAJ HH5 HZ~ IPNFZ IXB KQ8 M41 NCXOZ O-L O9- OK1 OZT RIG ROL SES SSZ XH2 ~S- ADJCN ADVLN AFJKZ AHFXO AKRWK AAYXX CITATION |
ID | FETCH-LOGICAL-c362t-b9ddf71474260876d898c06ffac1c71985b9dada51d02fb8ba678848dee58d6d3 |
IEDL.DBID | DOA |
ISSN | 1319-6103 |
IngestDate | Tue Oct 22 15:16:43 EDT 2024 Thu Sep 26 17:43:59 EDT 2024 Tue Nov 26 17:10:11 EST 2024 Thu Jul 20 20:02:06 EDT 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Chalcones Antifungal Antibacterial Pyrazolines Antitubercular |
Language | English |
License | This is an open access article under the CC BY-NC-ND license. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c362t-b9ddf71474260876d898c06ffac1c71985b9dada51d02fb8ba678848dee58d6d3 |
OpenAccessLink | https://doaj.org/article/d2a5c6b19c7f4719a1cb7457f79a0db5 |
PageCount | 8 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_d2a5c6b19c7f4719a1cb7457f79a0db5 crossref_primary_10_1016_j_jscs_2014_12_004 emarefa_primary_706554 elsevier_sciencedirect_doi_10_1016_j_jscs_2014_12_004 |
PublicationCentury | 2000 |
PublicationDate | 2016-09-01 |
PublicationDateYYYYMMDD | 2016-09-01 |
PublicationDate_xml | – month: 09 year: 2016 text: 2016-09-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Riyadh, Saudi Arabia |
PublicationPlace_xml | – name: Riyadh, Saudi Arabia |
PublicationTitle | Journal of Saudi Chemical Society |
PublicationYear | 2016 |
Publisher | Elsevier B.V Saudi Chemical Society Elsevier |
Publisher_xml | – name: Elsevier B.V – name: Saudi Chemical Society – name: Elsevier |
References | Sharma (b0090) 2007 Bashir, Ovais, Yaseen, Hamid, Alam, Samim, Singh, Javed (b0065) 2011; 21 Sharma, Sharma, Kumar, Dudhe (b0055) 2011; 65 Olczak, Daszkiewicz, Slawinska, Baginska, Gozdowski, Daszkiewicz, Fronc, Semczuk (b0005) 2012; 41 J.B. Ellen, R.P. Lancer, M.F. Sydney, Bailey and Scott’s Diagnostic Microbiology, ninth ed., Mosby, 2000. Baseer, Ansari, Ashraf (b0040) 2013; 26 Alvarez, Debattista, Pappano (b0025) 2008; 53 Rizvi, Siddiqui, Johns, Detorio, Schinazi (b0060) 2012; 21 Ozdemir, Kandilci, Gumusel, Calis, Bilgin (b0070) 2007; 42 (b0095) 1998 Kumar, Meenakshi, Kumar (b0045) 2013; 22 Sharshira, Hamada (b0035) 2012; 17 Abunada, Hassaneen, Kandile, Miqdad (b0075) 2008; 13 Husain, Ahmad, Mkhalid, Mishra, Rashid (b0085) 2013; 22 Alldredge, Corelli, Ernst, Guglielmo, Jacobson, Kradjan (b0020) 2013 Shaaban, Mayhoub, Farag (b0080) 2012; 22 Tuite, Lacey (b0015) 2013; 968 Kini, Gandhi (b0030) 2008; 70 Elmer, Stephen, William, Paul, Washing (b0100) 2002 Abid, Bhat, Athar, Azam (b0050) 2009; 44 Danishuddin, Kaushal, Hassan, Khan (b0010) 2012; 10 Alvarez (10.1016/j.jscs.2014.12.004_b0025) 2008; 53 Kumar (10.1016/j.jscs.2014.12.004_b0045) 2013; 22 Sharma (10.1016/j.jscs.2014.12.004_b0090) 2007 (10.1016/j.jscs.2014.12.004_b0095) 1998 Kini (10.1016/j.jscs.2014.12.004_b0030) 2008; 70 Tuite (10.1016/j.jscs.2014.12.004_b0015) 2013; 968 Olczak (10.1016/j.jscs.2014.12.004_b0005) 2012; 41 Danishuddin (10.1016/j.jscs.2014.12.004_b0010) 2012; 10 Baseer (10.1016/j.jscs.2014.12.004_b0040) 2013; 26 Bashir (10.1016/j.jscs.2014.12.004_b0065) 2011; 21 Shaaban (10.1016/j.jscs.2014.12.004_b0080) 2012; 22 Abid (10.1016/j.jscs.2014.12.004_b0050) 2009; 44 Ozdemir (10.1016/j.jscs.2014.12.004_b0070) 2007; 42 Rizvi (10.1016/j.jscs.2014.12.004_b0060) 2012; 21 Alldredge (10.1016/j.jscs.2014.12.004_b0020) 2013 Husain (10.1016/j.jscs.2014.12.004_b0085) 2013; 22 10.1016/j.jscs.2014.12.004_b0105 Elmer (10.1016/j.jscs.2014.12.004_b0100) 2002 Sharma (10.1016/j.jscs.2014.12.004_b0055) 2011; 65 Sharshira (10.1016/j.jscs.2014.12.004_b0035) 2012; 17 Abunada (10.1016/j.jscs.2014.12.004_b0075) 2008; 13 |
References_xml | – volume: 22 start-page: 253 year: 2012 end-page: 291 ident: b0080 article-title: Recent advances in the therapeutic applications of pyrazolines publication-title: Expert Opin. Ther. Pat. contributor: fullname: Farag – volume: 21 start-page: 4301 year: 2011 end-page: 4305 ident: b0065 article-title: Synthesis of some new 1,3,5-trisubstituted pyrazolines bearing benzene sulfonamide as anticancer and anti-inflammatory agents publication-title: Bioorg. Med. Chem. Lett. contributor: fullname: Javed – volume: 22 start-page: 1578 year: 2013 end-page: 1586 ident: b0085 article-title: Synthesis and antimicrobial activity of bischalcones derivatives publication-title: Med. Chem. Res. contributor: fullname: Rashid – year: 1998 ident: b0095 publication-title: Antifungal Agents: Past, Present and Future Prospects – volume: 22 start-page: 433 year: 2013 end-page: 439 ident: b0045 article-title: Synthesis and antimicrobial activity of some (3-phenyl-5-(1-phenyl-3-aryl-1 publication-title: Med. Chem. Res. contributor: fullname: Kumar – volume: 21 start-page: 3741 year: 2012 end-page: 3749 ident: b0060 article-title: Anti-HIV-1 cytotoxicity studies of piperidyl-thienyl chalcones and their 2-pyrazoline derivatives publication-title: Med. Chem. Res. contributor: fullname: Schinazi – year: 2007 ident: b0090 article-title: Manual of Microbiology Tools and techniques contributor: fullname: Sharma – volume: 26 start-page: 67 year: 2013 end-page: 73 ident: b0040 article-title: Synthesis, in vitro antibacterial and antifungal activity of some n-acetylated and non-acetylated pyrazolines publication-title: Pak. J. Pharm. Sci. contributor: fullname: Ashraf – volume: 41 start-page: 568 year: 2012 end-page: 576 ident: b0005 article-title: Bacteria and Candida yeasts in inflammations of the oral mucosa in children with secondary immunodeficiency publication-title: J. Oral Pathol. Med. contributor: fullname: Semczuk – volume: 968 start-page: 1 year: 2013 end-page: 23 ident: b0015 article-title: Overview of invasive fungal infections publication-title: Methods Mol. Biol. contributor: fullname: Lacey – volume: 17 start-page: 4962 year: 2012 end-page: 4971 ident: b0035 article-title: Synthesis and antimicrobial evaluation of some pyrazole derivatives publication-title: Molecules contributor: fullname: Hamada – volume: 10 start-page: 360 year: 2012 end-page: 363 ident: b0010 article-title: AMDD: antimicrobial drug database publication-title: Genomics Proteomics Bioinformatics contributor: fullname: Khan – year: 2002 ident: b0100 article-title: Text Book of Diagnostic Microbiology contributor: fullname: Washing – volume: 70 start-page: 105 year: 2008 end-page: 108 ident: b0030 article-title: Novel 2-pyrazoline derivatives as potential antibacterial and antifungal agents publication-title: Indian J. Pharm. Sci. contributor: fullname: Gandhi – volume: 13 start-page: 1011 year: 2008 end-page: 1024 ident: b0075 article-title: Synthesis and biological activity of some new pyrazoline and pyrrolo [3,4-c]pyrazole-4,6-dione derivatives: reaction of nitrilimines with some dipolarophiles publication-title: Molecules contributor: fullname: Miqdad – volume: 53 start-page: 23 year: 2008 end-page: 28 ident: b0025 article-title: Antimicrobial activity and synergism of some substituted flavonoids publication-title: Folia Microbiol. contributor: fullname: Pappano – volume: 44 start-page: 417 year: 2009 end-page: 425 ident: b0050 article-title: Synthesis, spectral studies and antiamoebic activity of new 1-N-substituted thiocarbamoyl-3-phenyl-2-pyrazolines publication-title: Eur. J. Med. Chem. contributor: fullname: Azam – volume: 42 start-page: 373 year: 2007 end-page: 379 ident: b0070 article-title: Synthesis and studies on antidepressant and anticonvulsant activities of some 3-(2-furyl)-pyrazoline derivatives publication-title: Eur. J. Med. Chem. contributor: fullname: Bilgin – year: 2013 ident: b0020 article-title: Applied Therapeutics: The Clinical Use of Drugs contributor: fullname: Kradjan – volume: 65 start-page: 244 year: 2011 end-page: 251 ident: b0055 article-title: A review on various heterocyclic moieties and their antitubercular activity publication-title: Biomed. Pharmacother. contributor: fullname: Dudhe – volume: 13 start-page: 1011 year: 2008 ident: 10.1016/j.jscs.2014.12.004_b0075 article-title: Synthesis and biological activity of some new pyrazoline and pyrrolo [3,4-c]pyrazole-4,6-dione derivatives: reaction of nitrilimines with some dipolarophiles publication-title: Molecules doi: 10.3390/molecules13041011 contributor: fullname: Abunada – year: 2007 ident: 10.1016/j.jscs.2014.12.004_b0090 contributor: fullname: Sharma – volume: 65 start-page: 244 year: 2011 ident: 10.1016/j.jscs.2014.12.004_b0055 article-title: A review on various heterocyclic moieties and their antitubercular activity publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2011.04.005 contributor: fullname: Sharma – volume: 70 start-page: 105 year: 2008 ident: 10.1016/j.jscs.2014.12.004_b0030 article-title: Novel 2-pyrazoline derivatives as potential antibacterial and antifungal agents publication-title: Indian J. Pharm. Sci. doi: 10.4103/0250-474X.40344 contributor: fullname: Kini – volume: 53 start-page: 23 year: 2008 ident: 10.1016/j.jscs.2014.12.004_b0025 article-title: Antimicrobial activity and synergism of some substituted flavonoids publication-title: Folia Microbiol. doi: 10.1007/s12223-008-0003-4 contributor: fullname: Alvarez – year: 2002 ident: 10.1016/j.jscs.2014.12.004_b0100 contributor: fullname: Elmer – volume: 26 start-page: 67 year: 2013 ident: 10.1016/j.jscs.2014.12.004_b0040 article-title: Synthesis, in vitro antibacterial and antifungal activity of some n-acetylated and non-acetylated pyrazolines publication-title: Pak. J. Pharm. Sci. contributor: fullname: Baseer – year: 1998 ident: 10.1016/j.jscs.2014.12.004_b0095 – volume: 22 start-page: 1578 year: 2013 ident: 10.1016/j.jscs.2014.12.004_b0085 article-title: Synthesis and antimicrobial activity of bischalcones derivatives publication-title: Med. Chem. Res. doi: 10.1007/s00044-012-0137-4 contributor: fullname: Husain – volume: 17 start-page: 4962 year: 2012 ident: 10.1016/j.jscs.2014.12.004_b0035 article-title: Synthesis and antimicrobial evaluation of some pyrazole derivatives publication-title: Molecules doi: 10.3390/molecules17054962 contributor: fullname: Sharshira – volume: 22 start-page: 433 year: 2013 ident: 10.1016/j.jscs.2014.12.004_b0045 article-title: Synthesis and antimicrobial activity of some (3-phenyl-5-(1-phenyl-3-aryl-1H-pyrazol-4-yl)-4,5-dihydro-1H-pyrazol-1-yl)(pyridin-4-yl) methanones: new derivatives of 1,3,5-trisubstituted pyrazolines publication-title: Med. Chem. Res. doi: 10.1007/s00044-012-0045-7 contributor: fullname: Kumar – volume: 21 start-page: 3741 year: 2012 ident: 10.1016/j.jscs.2014.12.004_b0060 article-title: Anti-HIV-1 cytotoxicity studies of piperidyl-thienyl chalcones and their 2-pyrazoline derivatives publication-title: Med. Chem. Res. doi: 10.1007/s00044-011-9912-x contributor: fullname: Rizvi – volume: 41 start-page: 568 year: 2012 ident: 10.1016/j.jscs.2014.12.004_b0005 article-title: Bacteria and Candida yeasts in inflammations of the oral mucosa in children with secondary immunodeficiency publication-title: J. Oral Pathol. Med. contributor: fullname: Olczak – volume: 42 start-page: 373 year: 2007 ident: 10.1016/j.jscs.2014.12.004_b0070 article-title: Synthesis and studies on antidepressant and anticonvulsant activities of some 3-(2-furyl)-pyrazoline derivatives publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2006.09.006 contributor: fullname: Ozdemir – volume: 10 start-page: 360 year: 2012 ident: 10.1016/j.jscs.2014.12.004_b0010 article-title: AMDD: antimicrobial drug database publication-title: Genomics Proteomics Bioinformatics doi: 10.1016/j.gpb.2012.04.002 contributor: fullname: Danishuddin – volume: 968 start-page: 1 issue: 2013 year: 2013 ident: 10.1016/j.jscs.2014.12.004_b0015 article-title: Overview of invasive fungal infections publication-title: Methods Mol. Biol. contributor: fullname: Tuite – volume: 21 start-page: 4301 year: 2011 ident: 10.1016/j.jscs.2014.12.004_b0065 article-title: Synthesis of some new 1,3,5-trisubstituted pyrazolines bearing benzene sulfonamide as anticancer and anti-inflammatory agents publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2011.05.061 contributor: fullname: Bashir – volume: 22 start-page: 253 year: 2012 ident: 10.1016/j.jscs.2014.12.004_b0080 article-title: Recent advances in the therapeutic applications of pyrazolines publication-title: Expert Opin. Ther. Pat. doi: 10.1517/13543776.2012.667403 contributor: fullname: Shaaban – year: 2013 ident: 10.1016/j.jscs.2014.12.004_b0020 contributor: fullname: Alldredge – volume: 44 start-page: 417 year: 2009 ident: 10.1016/j.jscs.2014.12.004_b0050 article-title: Synthesis, spectral studies and antiamoebic activity of new 1-N-substituted thiocarbamoyl-3-phenyl-2-pyrazolines publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2007.10.032 contributor: fullname: Abid – ident: 10.1016/j.jscs.2014.12.004_b0105 |
SSID | ssj0000070208 |
Score | 2.3859823 |
Snippet | In the present study, two new series of pyrazolines (3a–h &4a–h) were synthesized starting from p-acetamidophenol (paracetamol) and evaluated for their... In the present study, two new series of pyrazolines (3a–h & 4a–h) were synthesized starting from p-acetamidophenol (paracetamol) and evaluated for their... In the present study, two new series of pyrazolines (3a–h & 4a–h) were synthesized starting from p-acetamidophenol (paracetamol) and evaluated for their... |
SourceID | doaj crossref emarefa elsevier |
SourceType | Open Website Aggregation Database Publisher |
StartPage | 577 |
SubjectTerms | Antibacterial Antifungal Antitubercular Chalcones Pyrazolines |
Title | Synthesis, antimicrobial and antitubercular activities of some novel pyrazoline derivatives |
URI | https://dx.doi.org/10.1016/j.jscs.2014.12.004 https://search.emarefa.net/detail/BIM-706554 https://doaj.org/article/d2a5c6b19c7f4719a1cb7457f79a0db5 |
Volume | 20 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwELYoEmoviEJRt7TIh97aiHgTv46Ugjj1QpEq9WCNX9KibhZtdleiv56xnazg0l64Ok7G-saZGdvjbwj5jGYX_4Opq4RTsWpBQ6VDdJXDWMLKWoLOB-3XN_LHL_X9MtHkbEt9pZywQg9cgDvzU-BOWKadjGhINTBnZctllBpqbwt7aS2eLKZK4CtT9cm82mIa10d1M9yYKcldd71LXN2szXuBQ5W20Stl8v5nzmkvzAEfwRPXc3VA9oeYkZ6Xsb4lO6E7JK8vxlJtR-T3zUOHgVw_679SRGo2n2V6JXwHOp9bVmsbljnllKabDJvMo0oXkfaLeaDdYhP-0PuHJfxNNXwC9TgvN5kSvH9Hbq8uf15cV0PVhMqhM1pVVnsfJWtl4p5HW-eVVq4WMYJjDgFUHHuAB858PY1WWUB_pVrlQ-DKC98ck91u0YX3hDoOAFxY2STaN8vBClsr6wMToW6gmZAvI2rmvpBjmDFr7M4kjE3C2LCpQYwn5FsCdtszEVvnBlS3GdRt_qfuCeGjWswQIxTfj5-a_VP48aDDrfx0wMvbDy8xqhPyBmWJknv2keyuluvwibzq_fo0z8tHsjTn2g |
link.rule.ids | 315,782,786,866,2106,27933,27934 |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Synthesis%2C+antimicrobial+and+antitubercular+activities+of+some+novel+pyrazoline+derivatives&rft.jtitle=Journal+of+Saudi+Chemical+Society&rft.au=Ahmad%2C+Aftab&rft.au=Husain%2C+Asif&rft.au=Khan%2C+Shah+Alam&rft.au=Mujeeb%2C+Mohd&rft.date=2016-09-01&rft.pub=Elsevier+B.V&rft.issn=1319-6103&rft.volume=20&rft.issue=5&rft.spage=577&rft.epage=584&rft_id=info:doi/10.1016%2Fj.jscs.2014.12.004&rft.externalDocID=S1319610314001835 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1319-6103&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1319-6103&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1319-6103&client=summon |